history of glp-1 drugs glucagon-like peptide-1 receptor agonists Mapping the effectiveness and risks
Description
Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial
Mild prick only
For myocardial infarction, GLP-1RAs alleviate and repair MI via SIRT1/Parkin/mitophagy, insulin-like growth factor-1/2 and upregulating -estrogen receptor
Renal Extraction and Acute Effects of Glucagon-Like Peptide-1 on Central and Renal Hemodynamics in Healthy Men
E., Hayes, M
